{"filing":{"accession_number":"0001104659-26-078588","cik":"0002062583","ticker":"MMED","company_name":"MiniMed Group, Inc.","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"tm2619270d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2062583/000110465926078588/tm2619270d1_8k.htm"},"events":[{"id":14526,"run_id":12939,"accession_number":"0001104659-26-078588","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The Board appointed two new directors, David Endicott and Linnea Burman, effective June 29, 2026, increasing the Board size from nine to 11 members. Both appointments include full biographical details, independence determinations, and compensation arrangements.","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":11995,"accession_number":"0001104659-26-078588","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The Board appointed two new directors, David Endicott and Linnea Burman, effective June 29, 2026, increasing the Board size from nine to 11 members. Both appointments are disclosed with full biographical details, independence determinations, and compensation arrangements. Director appointments are material governance events affecting the composition and oversight of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T13:23:40.201736+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":14527,"run_id":12939,"accession_number":"0001104659-26-078588","anchor_item_number":"8.01","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.95,"summary":"MiniMed announced the date, time, location, and record date for its 2026 annual stockholder meeting, along with procedural deadlines for stockholder proposals and director nominations. These are routine administrative governance matters required by Delaware law and SEC rules.","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":11996,"accession_number":"0001104659-26-078588","item_number":"5.08","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.65,"reasoning":"Item 5.08 addresses shareholder nominations, a governance matter. The disclosure merely incorporates Item 8.01 by reference without substantive detail about the nominations themselves. Without the referenced Item 8.01 content, the materiality and specifics cannot be fully assessed, but the boilerplate incorporation language suggests this is likely a routine procedural disclosure rather than a material nomination event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T13:23:40.201736+00:00","company_name":"","ticker":null,"filing_date":""},{"id":11997,"accession_number":"0001104659-26-078588","item_number":"8.01","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.95,"reasoning":"This disclosure announces the date, time, location, and record date for MiniMed's 2026 annual stockholder meeting, along with procedural deadlines for stockholder proposals and director nominations. These are routine administrative governance matters required by Delaware law and SEC rules, not material events that would affect a reasonable investor's assessment of the company's financial condition or operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T13:23:40.201736+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11995,"accession_number":"0001104659-26-078588","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The Board appointed two new directors, David Endicott and Linnea Burman, effective June 29, 2026, increasing the Board size from nine to 11 members. Both appointments are disclosed with full biographical details, independence determinations, and compensation arrangements. Director appointments are material governance events affecting the composition and oversight of the company.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T13:23:40.201736+00:00","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-06-29"},{"id":11996,"accession_number":"0001104659-26-078588","item_number":"5.08","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.65,"reasoning":"Item 5.08 addresses shareholder nominations, a governance matter. The disclosure merely incorporates Item 8.01 by reference without substantive detail about the nominations themselves. Without the referenced Item 8.01 content, the materiality and specifics cannot be fully assessed, but the boilerplate incorporation language suggests this is likely a routine procedural disclosure rather than a material nomination event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T13:23:40.201736+00:00","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-06-29"},{"id":11997,"accession_number":"0001104659-26-078588","item_number":"8.01","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.95,"reasoning":"This disclosure announces the date, time, location, and record date for MiniMed's 2026 annual stockholder meeting, along with procedural deadlines for stockholder proposals and director nominations. These are routine administrative governance matters required by Delaware law and SEC rules, not material events that would affect a reasonable investor's assessment of the company's financial condition or operations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T13:23:40.201736+00:00","company_name":"MiniMed Group, Inc.","ticker":"MMED","filing_date":"2026-06-29"}]}